Effect of genetic factors on opioid action

Current Opinion in Anaesthesiology

Volumn 22, Issue 4, 2009, Pages 476-482

  Kosarac, Branka ^a   Fox, Amanda A ^b   Collard, Charles D ^c  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Anesthesia; Functional genomics; Gene; Opiate; Opiate receptor; Pharmacogenetics

Indexed keywords

ALFENTANIL; AMIODARONE; BUPIVACAINE; CATECHOL METHYLTRANSFERASE; CIMETIDINE; CODEINE; CYTOCHROME P450 2D6; DIHYDROCODEINE; DOPAMINE; FENTANYL; HYDROCODONE; METHADONE; MORPHINE; MU OPIATE RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 1; NORADRENALIN; OPIATE; PAROXETINE; RANITIDINE; TRAMADOL;

BLOOD BRAIN BARRIER; CANCER PAIN; CHRONIC PAIN; CONFUSION; DEMOGRAPHY; DROWSINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HALLUCINATION; HEREDITY; HUMAN; NIGHTMARE; PAIN; PATIENT CONTROLLED ANALGESIA; PHARMACOGENETICS; PHENOTYPE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE NAUSEA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANALGESICS, OPIOID; CATECHOL O-METHYLTRANSFERASE; CYTOCHROME P-450 CYP2D6; HUMANS; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU;

EID: 68949110020     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32832e34c9     Document Type: Review

References (29)

1. Palmer SN, Giesecke NM, Body SC, et al. Pharmacogenetics of anesthetic and analgesic agents. Anesthesiology 2005; 102:663-671.
2. Smith HS. Variations in opioid responsiveness. Pain Physician 2008; 11: 237-248.
3. Lavine G. Pharmacogenetics, therapeutic drug management offer new insights into treating pain. Am J Health Syst Pharm 2008; 65:1588-1590.
4. Ross JR, Riley J, Taegetmeyer AB, et al. Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer 2008; 112:1390-1403.
5. Rakvag TT, Ross JR, Sato H, et al. Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol Pain 2008; 4:64.
6. Reyes-Gibby CC, Shete S, Rakvag T, et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain 2007; 130:25-30.
7. Skorpen F, Laugsand EA, Klepstad P, et al. Variable response to opioid •• treatment: any genetic predictors within sight? Palliat Med 2008; 22:310-327.
8. Ahmedzai SH, Boland J. Opioids for chronic pain: molecular and genomic basis of actions and adverse effects. Curr Opin Support Palliat Care 2007; 1:117-125.
9. Stamer UM, Stuber F. Genetic factors in pain and its treatment. Curr Opin Anaesthesiol 2007; 20:478-484.
10. Stamer UM, Stuber F. The pharmacogenetics of analgesia. Expert Opin Pharmacother 2007; 8:2235-2245.
11. Nagashima M, Katoh R, Sato Y, et al. Is there genetic polymorphism evidence for individual human sensitivity to opiates? Curr Pain Headache Rep 2007; 11:115-123.
12. Chou WY, Yang LC, Lu HF, et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand 2006; 50: 787-792.
13. Chou WY, Wang CH, Liu PH, etal. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 2006; 105:334-337.
14. Kasai S, Hayashida M, Sora I, etal. Candidate gene polymorphisms predicting individual sensitivity to opioids. Naunyn Schmiedebergs Arch Pharmacol 2008; 377:269-281.
15. SiaAT, Lim Y, Lim EC, etal.A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesar-ean analgesia. Anesthesiology 2008; 109:520-526.
16. Hayashida M, Nagashima M, Satoh Y, et al. Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. Pharmacogenomics 2008; 9:1605-1616.
17. Landau R, Kern C, Columb MO, et al. Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain 2008; 139:5-14.
18. Hernandez-Avila CA, Covault J, Wand G, et al. Population-specific effects of the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1) on HPA-axis activation. Pharmacogenet Genomics 2007; 17:1031-1038.
19. Oertel BG, Schmidt R, Schneider A, et al. The mu-opioid receptor gene polymorphism 118AG depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. Pharmacogenet Genomics 2006; 16:625-636.
20. Foster A, Mobley E, Wang Z. Complicated pain management in a CYP450 2D6 poor metabolizer. Pain Pract 2007; 7:352-356.
21. Stamer UM, Stuber F, Muders T, et al. Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication. Anesth Analg 2008; 107:926-929.
22. Stamer UM, Musshoff F, Kobilay M, et al. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Clin Pharmacol Ther 2007; 82:41-47.
23. Kirchheiner J, Keulen JT, Bauer S, et al. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol. J Clin Psychopharmacol 2008; 28:78-83.
24. Kirchheiner J, Schmidt H, Tzvetkov M, et al. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J 2007; 7:257-265.
25. Levran O, O'Hara K, Peles E, et al. ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet 2008; 17:2219-2227.
26. Crettol S, Deglon JJ, Besson J, et al. No influence of ABCB1 haplotypes on methadone dosage requirement. Clin Pharmacol Ther 2008; 83:668-669.
27. Oosterhuis BE, LaForge KS, Proudnikov D, et al. Catechol-O- methyltransfer-• ase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:793-798.
28. CampaD,GioiaA,TomeiA,etal.AssociationofABCB1/MDR1 andOPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 2008; 83:559-566.
29. SlanarO, Nobilis M, Kvetina J, etal. Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T. Eur J Clin Pharmacol 2007; 63:419-421.